Dual GIP/GLP-1 action on hunger and glucose — the reliable middle path most people start with.
Batch-tested · COA on request · Research use only
A weekly injection that lowers appetite and keeps blood sugar steady. It is the most common place to start.
Helps you lose weight in a steady, predictable way, and most people find it easy to tolerate.
Activates two of your body's natural “full” switches at once. You feel satisfied on less food and your glucose stays more even through the day.
Tirzepatide acts on two receptors, balancing strong appetite reduction with steadier glucose. It is the most common starting point for those new to peptide therapy.